On February 25, Westvac had an industrial and commercial change, adding Shanghai Pharmaceutical(601607.SH), Chengdu Yike Investment Management Co., Ltd. and other shareholders. At the same time, the company’s registered capital increased from 10 million yuan  to 790 million yuan, an increase of 7800%, according to the data from Tianyancha APP.

Westvac was established in July 2020. The legal representative is Wei Yuquan. Its business scope includes biotechnology development, technical consulting, technology transfer, and pharmaceutical production.

Public information shows that Westvac is a biomedical company specializing in vaccine R&D and production and immunotherapy.